Prosjekt Euphoria: vellykket avslutning av første runde med salgsfremmende aktiviteter på norske salgssteder
Første fase av salgsfremmende aktiviteter i Norge er nettopp avsluttet. Dette er en del av «Euphoria» -prosjektet, et program for markedsføring av og informasjon om kvaliteten på europeisk frukt- og grønnsaksproduksjon, gjennomført med støtte fra Den europeiske union.
Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20220907005957/no/
(Photo: Enjoy Good Food)
En syklus med 50 salgsfremmende arrangementer ble gjennomført fra 18. august til 5. september for å øke forbrukernes bevissthet og verdsettelse av de unike egenskapene til europeisk frukt og grønnsaker. Kontrollerte og garanterte produksjonsprosesser som gir trygge produkter med kvaliteter og sanseegenskaper som er like unike som stedene de kommer fra.
Ved hjelp av kvalifiserte og opplærte vertinner nådde aktiviteten over 7000 forbrukere som fikk nyttig informasjon og verktøy for å hjelpe dem å bli mer bevisste når de kjøpte frukt og grønnsaker av europeisk opprinnelse i fremtiden.
De mest aktive forbrukerne ble også gjort kjent med den eksklusive og innovative "Enjoy Good Food" -emballasjen, dvs. en kjølepose laget av fuktbestandig papir, med isoterm innvendig og borrelåslukking, som inneholder et utvalg av utmerket frukt og grønnsaker av europeisk opprinnelse, og som kan gjenbrukes til shoppingturer og lagring av frukt og grønnsaker hjemme.
Euphoria-prosjektet vil nå slå av rampelyset i noen uker, akkurat lenge nok til at sesongproduksjonen kan presentere en ny kurv med utmerkede produkter for oktober måned. Ytterligere 50 kampanjearrangementer er planlagt for høsten, med Alto Viterbese IGP potet, Tonda Gentile Romana hasselnøtt og mange typiske høst/vinter grønnsaker.
Hvis du vil se dette innholdet fra cts.businesswire.com, gi ditt samtykke øverst på denne siden.
https://www.businesswire.com/news/home/20220907005957/no/
Contact information
Info@enjoygoodfood.eu
+390669202304
Om Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg pressemeldinger fra Business Wire
Registrer deg med din e-postadresse under for å få de nyeste sakene fra Business Wire på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra Business Wire
Mundipharma acquires all assets and rights related to REZZAYO ® (rezafungin) , reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area24.4.2024 22:01:00 CEST | Press release
Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafunginis a novel once-weekly echinocandin indicated for the treatment of invasive candidiasis in adults.1 Invasive candidiasis, is a severe, life-threatening infection of the bloodstream and/or deep/visceral tissues.2,3 It affects seriously ill people, especially those with a weakened immune systemand the mortality rate can be 40%4 or more.5,6 It can place a large burden on the healthcare system, with the potential for extended treatment regimens and long hospital stays.6 Over the last 15 years, there have been no new treatments and morbidity and mortality rates remain largely the same, indicating the need for alternative treatment options.7,8 “This acquisition places Mundipharma in the best position to realise the full potential of rezafungin inclu
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting24.4.2024 22:01:00 CEST | Press release
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024. “Our presentations at this year’s ASCO highlight the strength of our growing oncology portfolio and our commitment to developing treatments that address the unmet needs of patients with B-cell malignancies and solid tumors,” Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology at BeiGene. “The exciting data we will share during ASCO showcase BRUKINSA’s uniquely differentiated clinical profile and add to the growing body of evidence supporting its role across the blood cancer treatment paradigm.” BeiGene will share new data for BRUKINSA (zanubrutinib), which add to the robust efficacy and safety evidence differentiating it within the BTK class. Key highlights include: A network meta-analysis co
TSMC Celebrates 30 th North America Technology Symposium with Innovations Powering AI with Silicon Leadership24.4.2024 21:30:00 CEST | Press release
TSMC (TWSE: 2330, NYSE: TSM) today unveiled its newest semiconductor process, advanced packaging, and 3D IC technologies for powering the next generation of AI innovations with silicon leadership at the Company’s 2024 North America Technology Symposium. TSMC debuted the TSMC A16TM technology, featuring leading nanosheet transistors with innovative backside power rail solution for production in 2026, bringing greatly improved logic density and performance. TSMC also introduced its System-on-Wafer (TSMC-SoW™) technology, an innovative solution to bring revolutionary performance to the wafer level in addressing the future AI requirements for hyperscaler datacenters. This year marks the 30th anniversary of TSMC’s North America Technology Symposium, and more than 2,000 attended the event, growing from less than 100 attendees 30 years ago. The North America Technology Symposium in Santa Clara, California kicks off TSMC Technology Symposiums around the world in the coming months. The symposiu
Rimini Street Appoints Steve Hershkowitz as Chief Revenue Officer24.4.2024 18:50:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products, and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced the appointment of Steve Hershkowitz as its new Chief Revenue Officer (CRO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424061249/en/ Rimini Street Appoints Steve Hershkowitz as Chief Revenue Officer (Photo: Business Wire) “Steve’s leadership and extensive experience scaling businesses to deliver top-line growth will expand our sales reach to capture new logos and increase our opportunity to provide even greater value to our clients,” said Rimini Street president and CEO Seth Ravin. “The global revenue team and I are excited to work closely together with Steve to drive growth and broader capabilities for our company.” Leading the Next Chapter of Sales Growth and Continued Success f
Hithium Hosts Roundtable at the BNEF Summit New York, Discussing Next Generation Battery Energy Storage System24.4.2024 18:00:00 CEST | Press release
From April 16th to 17th, the BloombergNEF (BNEF) Summit was held in New York, USA. The BNEF Summit brings together energy, finance, and technology professionals to facilitate the exchange of ideas, insights, and connections. This was Hithium's first time attending after its global launch in 2023. Hithium was also invited to host a roundtable discussion on the topic of "Next Generation Battery Energy Storage System: Latest Technology Trends and Impact on Project Economics," led by Hithium Director of Global Applications Engineering, Neil Bradshaw. The discussion focused on the future development trends of energy storage and included insights on Hithium's technology innovations, global application practices, and international development for global energy green transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423336349/en/ BNEF summit roundtable hosted by HiTHIUM (Photo: Business Wire) Hithium’s advantages on